Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Friday 15 March, 2019

US Solar Fund PLC

Offer Update

RNS Number : 0640T
US Solar Fund PLC
15 March 2019
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, TO US PERSONS OR INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION WHERE, OR TO ANY OTHER PERSON TO WHOM, TO DO SO WOULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER TO SELL OR ISSUE, OR ANY SOLICITATION OF ANY OFFER TO PURCHASE, SUBSCRIBE FOR OR OTHERWISE ACQUIRE, ANY INVESTMENTS IN ANY JURISDICTION.

15 March 2019

US SOLAR FUND PLC

("US Solar Fund" or the "Company")

Offer Update

 

Further to the Prospectus issued by the Company on 26 February 2019 (the "Prospectus"), the Board of Directors of US Solar Fund plc, a newly established investment company focused on investing in Solar Power Assets primarily in the United States, provides an update on its proposed Initial Public Offering (the "Offer").

 

The Board is very pleased with the strong response to the Offer received from a broad range of investors, which includes a number of large, blue-chip institutions, particularly in light of current political and economic uncertainty. A small number of additional investors require further time to complete their due diligence. Accordingly, the Board has decided on a short extension of the timetable in respect of the Offer. The Company intends to publish the revised timetable next week.

 

FOR FURTHER INFORMATION ON THE COMPANY, PLEASE CONTACT:

 

Fidante Capital

John Armstrong-Denby / Nick Donovan

 

020 7832 0900

Tulchan Communications

Elizabeth Snow / Sheebani Chothani

 

0207 353 4200

 

Further information on the Company can be found on its website at www.ussolarfund.co.uk

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
FURJAMITMBBBBAL

a d v e r t i s e m e n t